Mellan nödvändigt samarbete och skadlig maskopi: En WPR-analys av hur EC, EFPIA och CEO arbetar för att (de)legitimera EU:s regleringar av läkemedelsindustrin
Although the coronavirus pandemic has highlighted the importance of easily accessible medicines, a reactive pharmaceutical industry and the effects of how the same industry sector is regulated, the EU’s pharmaceutical regulations still have apparent flaws. Therefore, this WPR study intends to visualize how EC, EFPIA, and CEO have tried to maintain or undermine these regulations over time. To enabl